news Archives - Page 3 of 100 - Journal for Clinical Studies

Current Edition

Volume 18, Issue 1

Europe

CPhI post-pandemic executive pharma survey: COVID-19 driving manufacturing and CDMOs driving growth

Executives are extremely bullish on pharma’s business outlook for both the short and medium term Ahead of CPhI Discover (17th-28th May 2021) – global pharma’s larg...

26 April 2021 Europe | news

Continue Reading →

Europe

SGS Facilitates Selecta Biosciences and AskBio’s FIH Study to Evaluate ImmTOR™ in Gene Therapy

SGS is pleased to announce the support of Selecta Biosciences and Asklepios BioPharmaceutical, Inc. (AskBio) Phase 1 dose-escalation trial of SEL-399, an adeno-...

30 March 2021 Europe | news

Continue Reading →

news

CPhI Worldwide Announces New November 2021 Dates

At CPhI Worldwide, we understand the importance of meeting face-to-face with your peers and potential business partners. In 2021 we will bring the global pharma comm...

15 January 2021 news | Regional News

Continue Reading →

news

Japan’s Kobayashi Kako admits manufacturing mix-up led to patient’s death

A "grave" manufacturing error in Japan tainted antifungal tablets with high doses of a sleep medication, leading to the death of one woman in her 70s and side effect...

21 December 2020 news | Regional News

Continue Reading →

news

AbbVie’s Botox wins reprieve as agency bars Evolus’ Jeaveau for alleged trade-secrets theft

AbbVie's aiming to make the most out of its new moneymaker Botox, gained in its Allergan megamerger last year, and it just scored a legal win—against ...

21 December 2020 news | Regional News

Continue Reading →

news

MacroGenics HER2 drug scores FDA breast cancer nod with Herceptin-topping data

MacroGenics’ oncology med Margenza is launching into the crowded HER2-positive breast cancer field. But the company has one advantage it can tout: The drug topped Ro...

21 December 2020 news | Regional News

Continue Reading →

news

Lilly and Regeneron COVID-19 antibodies are available all over the U.S. Why aren’t they getting to more patients?

About a month after the FDA issued emergency authorizations for COVID-19 antibodies from Eli Lilly and Regeneron, most of them have gone unused, a federal official s...

21 December 2020 news | Regional News

Continue Reading →

news

Biogen inks $22M charity kickbacks deal with feds, but argues its conduct was appropriate

Over the last few years, the federal government has inked charity kickback settlements with a who’s who of pharma companies. With a new Department of Justice settlem...

21 December 2020 news | Regional News

Continue Reading →

news

Fierce Pharma Asia—BioNTech-Fosun COVID-19 vax supply; Samsung Biologics’ new CEO; blank Avigan review

As BioNTech makes inroads with Pfizer for their COVID-19 vaccine in the Western world, the German biotech has agreed to supply 100 million doses for its Chinese...

21 December 2020 news | Regional News

Continue Reading →

news

FDA reviewers argue for Novartis ahead of Entresto advisory panel confab

Novartis’ Entresto chalked up a high-profile flop in a heart failure study last year, but the Swiss pharma shot for an FDA approval anyway. Now, reviewers at the age...

15 December 2020 news | Regional News

Continue Reading →